FindTrial
Sign In

Screening methods of cervical cancer- A comparative analysis

A comparative analysis of visual inspection with acetic acid, cervical cytology and histopathology in screening and early detection of carcinoma cervix

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/08/027023
Enrollment
500
Registered
2020-08-07
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C539- Malignant neoplasm of cervix uteri, unspecified

Interventions

Intervention1: NIL: NIL Intervention2: NIL: NIL

Sponsors

Gajra Raja Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All sexually active women and women in reproductive age group with recurrent episodes of white discharge, postcoital bleeding and intermenstrual bleeding.

Exclusion criteria

Exclusion criteria: Women who refused to give consent and known cases of cervical carcinoma, pregnant women, women with active vaginal bleeding

Design outcomes

Primary

MeasureTime frame
For women who are devoid of any screening test, VIA based screenng will be a good screening tool.Timepoint: At the end of the study (i.e, 1 year)—

Secondary

MeasureTime frame
To calculate the sensitivity and specificity of VIA screeing of carcinoma cervix.Timepoint: At the end of the study (i.e, 1 year)—

Countries

India

Contacts

Public ContactJaphia David

Gajra Raja Medical College

vrundajoshi45@gmail.com9425112132

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026